As its predicted GLP-1 use will continue to rise in OSA patients, a common topic in discussions, according to Peters, is how GLP-1s might affect the use of other sleep apnea therapies, like CPAP, oral appliances, and hypoglossal nerve stimulation
Key takeaways FDA-approved semaglutide products include Ozempic, Wegovy, and Rybelsus
Back pain, a common and often debilitating condition, affects millions of people worldwide, making it important to explore new treatment options
Contemporary research applications span diverse fields including aging biology, tissue regeneration, cancer research, and regenerative medicine, with laboratory models demonstrating remarkable restoration of tissue homeostasis in both accelerated and natural aging conditions